✦ LIBER ✦

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

✍ Scribed by Asgerdur Sverrisdottir; Hemming Johansson; Ulla Johansson; Jonas Bergh; Samuel Rotstein; LarsErik Rutqvist; Tommy Fornander

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 316 KB
Volume: 128
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1593-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endocrine consequences of CMF adjuvant t

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients

✍ Ann M. Dnistrian; Morton K. Schwartz; Alfred A. Fracchia; Richard J. Kaufman; Th 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 3 views

Toremifene is an effective and safe alte

Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials

✍ Wen-Bin Zhou; Qiang Ding; Ling Chen; Xiao-An Liu; Shui Wang 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 375 KB

Randomized trial to evaluate the additio

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

✍ James N. Ingle; Lloyd K. Everson; H. Sam Wieand; Stephen A. Cullinan; Lester E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Progesterone receptor is a significant f

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

✍ Shuzhen Liu; Stephen K. Chia; Erika Mehl; Samuel Leung; Ashish Rajput; Maggie C. 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 415 KB

Safety of zoledronic acid and incidence

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

✍ R. Coleman; E. Woodward; J. Brown; D. Cameron; R. Bell; D. Dodwell; M. Keane; M. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 339 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views